LSB Industries $187 million secondary offering
The stock is listed on the New York Stock Exchange
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Terns Pharmaceuticals $65 million common stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Arrival $300 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Canoo $200 million at-the-market offering
The stock offering is SEC-registered
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
RxSight $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
TransMedics Group $150 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Exelon $1 billion at-the-market offering
Exelon may enter into forward sale transactions under the at-the-market program
Allakos $75 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Legend Biotech $403 million follow-on offering
The shares are listed on the Nasdaq Global Select Market